Study title: Double-blind, multinational, multicentre, parallel-group, placebo-controlled design clinical trial of the efficacy and safety of nebulized beclomethasone dipropionate (400 mcg b.i.d.) plus as needed salbutamol versus as needed salbutamol or as needed salbutamol/beclomethasone fixed combination, in the 12-week treatment of young childrem with asthma symptoms.please see report
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: SALBUTAMOL AND BECLOMETHASONE DIPROPIONATE | |||||
ATC code: | |||||
Document link: MC.PR.1404.002.05 publication.pdf | |||||
Document date: 2015-03-02 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |